Recently, we reported that with CERS2 KD alone, we observed changes in many pathways crucial for worsening cardiac hypertrophy, suggesting CERS2 KD and the corresponding reduction of cellular levels of VLC sphingolipids, by itself, influence a HF phenotype within these cells [15]. The gene discussed is CERS2; the disease is hydrops fetalis.